Its integration into the target cell nucleus can lead to the inactivation of the p53 (a transcription factor regulating the cell cycle) and Rb (retinoblastoma protein) tumor suppressor proteins, thereby modulating the proliferative activity of cells and extending the lifespan of tumor cells. The gene discussed is TP53; the disease is neoplasm.